PharmaBridge International

PharmaBridge International is a healthcare enterprise registered under the Government of India, founded in June 2024 and headquartered in Ghaziabad, Uttar Pradesh. As a proud subsidiary of Mahimedicos, the company is dedicated to offering affordable, high-quality, and FDA-approved pharmaceutical products to patients across the globe.

With a growing international presence in regions like the USA, UK, and Australia, PharmaBridge International provides a comprehensive range of therapeutic solutions while maintaining full compliance with global regulatory standards. By integrating advanced technology and evidence-based research, the company addresses diverse healthcare needs—from long-term chronic care to innovative treatment options.

PharmaBridge International partners with leading healthcare providers, research institutions, and logistics networks to ensure a consistent and timely supply of essential medicines. Its strong infrastructure, combined with a patient-centric vision, helps the company stand out as a trusted name in the pharmaceutical industry.

The core mission of PharmaBridge International is to close the gap in healthcare accessibility by delivering modern, effective treatments worldwide. With an unwavering commitment to quality, integrity, and patient safety, the company is playing a transformative role in improving global health and well-being.